| Lipids Management |
0 |
0.9 |
| Statins |
0 |
0.88 |
| Myalgia |
0 |
0.41 |
| Muscle |
0 |
0.38 |
| Pain Management |
0 |
0.33 |
| Pain |
0 |
1 |
| Washington |
0 |
0.15 |
| Patient Safety |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Atherosclerosis |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.06 |
| PCSK9 |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.03 |
| Aspirin |
0 |
0.03 |
| Board Certification |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Clerkship |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Health Care Reform |
0 |
0.03 |
| Heart |
0 |
0.03 |
| HIV Infection |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Internship |
0 |
0.03 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.03 |
| Outpatient Clinic |
0 |
0.03 |
| Students |
0 |
0.03 |
| Thyroid |
0 |
0.03 |
| Thyroid Disease |
0 |
0.03 |
| Vitamin |
0 |
0.03 |